Literature DB >> 19571019

Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions.

L M Cavaco1, F M Aarestrup.   

Abstract

Fluoroquinolone resistance in members of the Enterobacteriaceae family is mostly due to mutations in the quinolone resistance-determining regions of the topoisomerase genes. However, transferable genes encoding quinolone resistance have recently been described. The current methods for susceptibility testing are not adapted to the detection of new resistance determinants, which confer low levels of resistance. The aim of this study was to compare the ability of the screening of the different quinolones by disk diffusion assays and MIC determinations to detect fluoroquinolone resistance. Sixty-nine Escherichia coli strains and 62 Salmonella strains, including strains fully susceptible to quinolones, nalidixic acid-resistant strains, strains with resistance to fluoroquinolones (resistant to nalidixic acid), and strains showing low-level resistance to fluoroquinolones conferred by transferable quinolone resistance genes, including qnrA, qnrB, qnrS, and aac(6')Ib-cr, were selected. Disk diffusion assays and MIC determinations by the agar dilution method were performed, according to CLSI standards, with nalidixic acid, flumequine, oxolinic acid, ciprofloxacin, enrofloxacin, marbofloxacin, norfloxacin, ofloxacin, and levofloxacin. The MIC of levofloxacin was determined by an Etest. The results showed a trimodal distribution of the MICs for both E. coli and Salmonella. The MIC distributions for the isolates varied with the compounds tested. Screening for nalidixic acid resistance by MIC testing or disk diffusion assay was not efficient for the detection of some of the isolates carrying qnr and aac(6')Ib-cr. Transferable resistance genes would best be detected by testing for the MIC of ciprofloxacin or norfloxacin, as testing for the MICs of the other compounds would fail to detect isolates carrying aac(6')Ib-cr because the enzyme produced is able to reduce the activities of these two compounds only due to their chemical structures. In conclusion, screening with nalidixic acid is efficient for the detection of mutants, but it is not so efficient for the detection of qnr and aac(6')Ib-cr. Detection would be maximized by screening with either ciprofloxacin or norfloxacin by both MIC determination and disk diffusion assays. Furthermore, a low concentration of ciprofloxacin (1 microg) in the disks seemed to increase the sensitivity of the disk diffusion assay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571019      PMCID: PMC2738116          DOI: 10.1128/JCM.00456-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Plasmid-mediated quinolone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated in Denmark and Thailand.

Authors:  L M Cavaco; R S Hendriksen; F M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2007-07-16       Impact factor: 5.790

3.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

Authors:  Ari Robicsek; Jacob Strahilevitz; George A Jacoby; Mark Macielag; Darren Abbanat; Chi Hye Park; Karen Bush; David C Hooper
Journal:  Nat Med       Date:  2005-12-20       Impact factor: 53.440

4.  Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.

Authors:  H Wang; J L Dzink-Fox; M Chen; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  qnrB, another plasmid-mediated gene for quinolone resistance.

Authors:  George A Jacoby; Kelley E Walsh; Debra M Mills; Victoria J Walker; Herin Oh; Ari Robicsek; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

7.  Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b.

Authors:  Mami Hata; Masahiro Suzuki; Masakado Matsumoto; Masao Takahashi; Katsuhiko Sato; Shiro Ibe; Kenji Sakae
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.

Authors:  M Oethinger; W V Kern; A S Jellen-Ritter; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.

Authors:  Kunikazu Yamane; Jun-ichi Wachino; Satowa Suzuki; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

10.  Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions.

Authors:  L M Cavaco; F M Aarestrup
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

View more
  25 in total

1.  Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals.

Authors:  Patricia J Baudry-Simner; Amanpreet Singh; James A Karlowsky; Daryl J Hoban; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Resistance gene transfer during treatments for experimental avian colibacillosis.

Authors:  Alexandra Dheilly; Laëtitia Le Devendec; Gwenaëlle Mourand; Axelle Bouder; Eric Jouy; Isabelle Kempf
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

3.  Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.

Authors:  Robert Skov; Erika Matuschek; Maria Sjölund-Karlsson; Jenny Åhman; Andreas Petersen; Marc Stegger; Mia Torpdahl; Gunnar Kahlmeter
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

4.  Characterization of isolates of Salmonella enterica serovar Stanley, a serovar endemic to Asia and associated with travel.

Authors:  Rene S Hendriksen; Simon Le Hello; Valeria Bortolaia; Chaiwat Pulsrikarn; Eva Møller Nielsen; Srirat Pornruangmong; Phattharaporn Chaichana; Christina Aaby Svendsen; François-Xavier Weill; Frank M Aarestrup
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

5.  Occurrence and Spread of Quinolone-Resistant Escherichia coli on Dairy Farms.

Authors:  Anna Duse; Karin Persson Waller; Ulf Emanuelson; Helle Ericsson Unnerstad; Ylva Persson; Björn Bengtsson
Journal:  Appl Environ Microbiol       Date:  2016-06-13       Impact factor: 4.792

6.  Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.

Authors:  Maria Sjölund-Karlsson; Rebecca L Howie; John A Crump; Jean M Whichard
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

Review 7.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

8.  Unexpected distribution of the fluoroquinolone-resistance gene qnrB in Escherichia coli isolates from different human and poultry origins in Ecuador.

Authors:  Paulina I Armas-Freire; Gabriel Trueba; Carolina Proaño-Bolaños; Karen Levy; Lixin Zhang; Carl F Marrs; William Cevallos; Joseph N S Eisenberg
Journal:  Int Microbiol       Date:  2015-06       Impact factor: 2.479

9.  Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina.

Authors:  Patricia Andres; Celeste Lucero; Alfonso Soler-Bistué; Leonor Guerriero; Ezequiel Albornoz; Tung Tran; Angeles Zorreguieta; Marcelo Galas; Alejandra Corso; Marcelo E Tolmasky; Alejandro Petroni
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

10.  Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions.

Authors:  L M Cavaco; F M Aarestrup
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.